08. May 2025 | Corporate News

Marinomed Biotech AG announces results for the first quarter of 2025

  • Revenues for the first quarter of 2025 increased to EUR 6.5 million compared to EUR 0.7 million in Q1 2024 -steep increase of operating result to EUR 22.2 million compared to EUR -1.9 million Q1 2024
  • Cash and cash equivalents increased to EUR 4.5 million compared to EUR 1.7 million in Q1 2024
  • Investigations concerning the cyber fraud are ongoing; Despite the case the company is within its plans concerning liquidity

The full press release is available as download here:

Marinomed Biotech AG announces results for the first quarter of 2025
(504 KB)